Objective.-To establish the health-related quality of life of patients with cervicogenic headache and to compare it with a random Dutch sample of control subjects and with patients with migraine without aura or with episodic tension-type headache.
published by Sjaastad et al in 1990 with a recent revision in 1998, enabling researchers to select patients rigorously for future trials. 5 Although the diagnosis of CGH is controversial, 6, 7 we have recently demonstrated the clinical validity to diagnose this headache syndrome. 8, 9 There is increasing literature on the diagnosis and treatment of CGH, but epidemiological data are scarce. 10 In particular, little is known about the extent to which quality of life (QoL) is impaired in patients with CGH. Many studies underscore the impact of chronic headaches on patients' QoL. [11] [12] [13] [14] [15] [16] [17] Although there is some debate on how QoL should be measured in patients with headache, consensus exists that health-related QoL (HRQoL) is a reliable tool. 11, 13, 17, 18 Health-related QoL is an expression of one's perceptions of their position in life that is affected by physical health, psychological state, and social relationships. It includes subjective perceptions of one's life situation in the context of the culture and value system in which they live and in relation to their goals, expectations, and standards. Assessment of HRQoL makes it possible to quantify the burden of illness and to compare the burden with healthy people or among different disorders (eg, headaches). The subjective nature of headache and the absence of objective clinical end points have left clinicians without an objective standard by which to judge the impact of headache on patients. Therefore, the RAND Corporation developed an instrument of HRQoL assessment-the Medical Outcomes Study (MOS) 36-Item Short Form (SF-36) questionnaire. 16, 19, 20 The SF-36 is a brief generic questionnaire that serves as a valuable instrument determining differences in functional status and well-being among the different headache syndromes. 13 Until now, all reports have referred to HRQoL studies of patients with migraine, tension-type headache (TTH), chronic daily headache, or cluster headache (CH). There is no previous experience in assessing the HRQoL of patients with CGH. The aim of our study was to apply the SF-36 questionnaire to patients with CGH and to determine the impact on HRQoL in these patients, and to evaluate differences in functional health status between patients with CGH and patients with migraine without aura (MWOA) or episodic tension-type headache (ETTH).
PATIENTS AND METHODS
The Medical Ethical Committee of the University Hospital Maastricht approved the study protocol, and written informed consent was obtained from every patient before entry into the study. The study sample consisted of 118 patients with headache, 85 women and 33 men (Table 1) . Experienced neurologists made the various headache diagnoses. Patients with MWOA or ETTH were diagnosed according to the International Headache Society (IHS) classification. 21 Patients with CGH were diagnosed according to the criteria from Sjaastad et al. 5 Patients fulfilled both parts I and III of the major criteria. We felt that the unilaterality of the pain is a crucial part of the diagnosis of CGH. At the start of the study, these criteria had not yet been published, so a minority of patients in our study did not undergo local anesthetic blocks, which is part II of the major criteria. 5 Sjaastad's criteria were used as this study was part of an ongoing research project to evaluate the validity of these criteria. We were able to show that the diagnostic concept of CGH has a reasonable interobserver agreement, even without the restrictive radiological criteria of the IHS classification (code 11.2.1, headache associated with disorder of the neck). 8, 9 Patients were recruited either during their first appointment with their neurologist or at random from the computerized database of patients with headache from the Department of Neurology at the University Hospital Maastricht. During the initial visit and after satisfying the inclusion and exclusion criteria ( the University Hospital Maastricht. All patients filled out their questionnaire at the hospital. The data manager (S.S-vdB. or I.L.) checked the questionnaires for missing data before the patient left the hospital.
The questionnaire used for measuring HRQoL was the translated Dutch version of the SF-36-a Table 3 . The SF-36 domain scores were taken from the SF-36 Health Survey Manual and Interpretation Guide. 29 The raw item scores were summed up to form domain scores and transformed to a 100-point scale. The SF-36 domain scores range from 0 to 100, a high score indicates a higher level of function or well-being. We analyzed the domain scores of the group with CGH and compared them with those of a control group. The control group domain scores were derived from a study by van der Zee et al. 22 This group of 295 was chosen from a random sample survey from the population register of Emmen, The Netherlands. Mean age was 44.1 years (range, 18 to 89), with a female preponderance of 65%. Because in our study 3 domain scores (ie, PF, RP, and RE) were not normally distributed, we analyzed our data using the Mann-Whitney nonparametric test. To compare our results with those of other studies, which used Student t tests, we also performed this analysis comparing the HRQoL of patients with CGH with that of patients with migraine or TTH. No substantial differences were found in the analysis of our results with the parametric Student t test. In this study, the scores of the 8 SF-36 domains were compared among the 3 headache diagnoses by 1-way analysis of variance (ANOVA). Statistical significance was set at P < .05. We used the statistical software package for the social sciences (SPSS, version 9.0).
RESULTS
One hundred eighteen patients (Table 1) completed the SF-36 questionnaire. The mean age of patients with CGH was 48.3 years (SD, 11.1); in the patients with TTH, 41.4 years (SD, 14.5); and in the group with migraine, 39.1 years (SD, 11.1). There was a statistical difference (P < .05) in the mean age between those with CGH and migraine and between those with CGH and TTH. Patients with CGH were older. Between those with migraine and TTH, no significant difference in mean age was found. In all groups, there was a female preponderance: 73% in the patients with CGH, 66.7% in the patients with TTH, and 76.9% in the patients with migraine. The control group was not significantly different from the CGH group with respect to age and gender. Missing SF-36 data were not detected. The SF-36 mean domain scores of the CGH group were all significantly worse than those of the control group (Table 4) . The HRQoL of patients with CGH was most profoundly affected in the domains of RP and BP (Figure 1) . Statistics from ANOVA showed a level of significance only for PF. Comparisons of the SF-36 mean domain scores between patients with CGH, migraine, and TTH are given in Table 5 . The mean domain score for PF was significantly worse for those with CGH compared with those with migraine and TTH. Compared with migraineurs, patients with TTH scored lower on PF. Figure 2 shows scores for the control subjects and patients with CGH, migraine, and TTH as outlined in Table 5 .
COMMENTS
Patients with CGH have never been subjected to assessment of HRQoL. This is the first study demonstrating that patients with CGH have worse HRQoL than a healthy community sample (Table 4) . They score significantly worse on all 8 SF-36 domains, indicating that the degree of disability in CGH is substantial and must not be underestimated (Figure 1 ). The lowest domain scores (ie, <50) in patients with CGH were found in RP and BP. Patients in our study with migraine or TTH also had the lowest domain scores in RP and BP. These results are consistent with the findings in other headache studies, although the level of severity differs; eg, BP scores are worse in those with CH compared to those with CGH, migraine, or TTH. 11, 13, 17 As QoL is affected in patients with headache, we sought to assess this in patients with CGH. Using the SF-20 questionnaire (the precursor to the SF-36), Solomon et al reported that distinct headache between patients with CGH and patients with migraine (Table 5) . A worse score for PF means that common daily activities such as walking, shopping, cleaning the house, etc are impaired. It has been shown that the impact of headache on HRQoL depends to a great extent on the chronicity of the headache or the frequency of attacks. 17, 30 Although the pattern of headache attacks may vary intra-individually in patients with CGH, eventually it develops into a more or less chronic fluctuating pattern in most patients. 1, 4 Therefore, more days with headache could be an explanation for the lower score for PF in our patients with CGH. In our study, however, we have not adjusted our data for the frequency of migraine attacks nor for the days with headache in those with CGH or TTH.
Comparing the domain scores of patients with migraine from the study by Monzón and Láinez with our patients with CGH demonstrates PF is the only significantly different score (Table 6) . We also compared our data with the results from population-based QoL studies of patients with migraine that used the SF-36 questionnaire (Table 6) . 13, 23 We found that PF was also statistically significantly worse in patients with CGH compared with migraineurs from these studies. Furthermore, whether this is a unique pattern of impairment for CGH or just a coincident finding related to the more chronic character of the headache or the older age group of CGH (or both) remains to be established. Bodily pain measures the severity of the pain (ie, the headache) during the previous 4 weeks. Patients with CGH demonstrated a substantially worse score for BP compared with the control group (Table 4) . Although the patients with CGH demonstrated the lowest score in BP, it differed not significantly with the BP score of the patients with migraine or TTH (Table 5 ). Comparing our results regarding BP with other studies, however, we found a statistically significant difference with the studies by Osterhaus et al and Aaronson et al, but not in the study by Monzón and Láinez (Table 6) . 13, 17, 23 A possible explanation for this significant difference in BP could be the method of patient selection. Patients in our study and from the study by Monzón and Láinez were recruited from hospitals, while the patients from Aaronson et al and from Osterhaus et al were selected from the community. On average, patients with headache who consult physicians and specialized headache clinics have more severe headache than patients in the community. 11, 14, 31, 32 Some other domain scores in the 2 population-based migraine studies were also significantly different compared to those of patients with CGH, however without a consistent pattern (Table 6 ). It must be stressed that comparison of data from the SF-36 questionnaires between studies should be done cautiously due to confounding factors such as patient selection, crosscultural differences, etc.
The present data demonstrate that the impairment of QoL in those with CGH is worse compared to healthy persons but is, in general, comparable with patients with migraine and TTH. Although there is no previous experience in CGH, our results suggest that the SF-36 questionnaire is valuable in determining differences in QoL among different headache syndromes and might be used as a primary outcome measure in clinical trials on CGH. Cervicogenic headache may have a unique pattern of disability compared to migraine where PF is concerned. This may be due, however, to the more chronic character of this headache and therefore not specific for CGH.
